For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Ctc Bio, Inc.

USPTO Granted Patents = 14

% Expired Patents = 21.4

EPO Patents = 8

Forward Citations = 14

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Bong-Sang Lee (10 out of 18 patents)

Hong Ryeol Jeon (7 out of 10 patents)

Do-Woo Kwon (7 out of 7 patents)

4. Su-Jun Park (7 out of 8 patents)

5. Hong-Ryeol Jeon (5 out of 5 patents)

6. Seong-Shin Kwak (3 out of 3 patents)

7. Jiyeong Han (3 out of 3 patents)

8. Myeongcheol Kil (3 out of 3 patents)

9. Bong-Geun Cha (2 out of 2 patents)

10. Jun-Ki Kim (2 out of 2 patents)

11. Dong-Jin Lee (2 out of 7 patents)

12. Hyun-Jung Park (2 out of 3 patents)

13. Jung-Hwa Kim (2 out of 2 patents)

14. Ki-Hong Sung (2 out of 2 patents)

15. Se-Geun Yu (2 out of 2 patents)

14 patents: Sort by Forward Citations

1. 11266658 - Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration (2022-03-08),

2. 11116769 - Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer (2021-09-14),

3. 10512610 - Pharmaceutical composition containing clomipramine and preparation method therefor (2019-12-24),

4. 10213437 - Pharmaceutical preparation for masked taste oral administration, containing clomipramine (2019-02-26),

5. 10045993 - Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor (2018-08-14),

6. 10045944 - Pharmaceutical composition containing clomipramine and preparation method therefor (2018-08-14),

7. 10004769 - Lactobacillus brevis G-101 strain and use thereof (2018-06-26),

8. 9907759 - Sildenafil-free base-containing film preparation and method for producing same (2018-03-06),

9. 9504721 - Bacteriophage and its use for preventing proliferation of pathogenic bacteria (2016-11-29),

10. 9492446 - Manufacturing method of solid dispersion containing itraconazole (2016-11-15),

11. 9339511 - Pharmaceutical formulation containing choline alfoscerate (2016-05-17),

12. 8633176 - Pharmaceutical formulation containing choline alfoscerate (2014-01-21),

13. 8343555 - Composition and method for treating or preventing white spot syndrome virus (2013-01-01),

14. 6984406 - [object Object] (2006-01-10),

Company Overview

Ctc Bio, Inc. is a biotechnology company based in Seoul, South Korea, specializing in the development and manufacturing of innovative biopharmaceutical products. The company focuses on advanced therapeutic solutions, particularly in the fields of immunology and oncology. Ctc Bio leverages cutting-edge technologies to enhance drug development processes, aiming to improve patient outcomes through targeted therapies. Its commitment to research and development positions it as a key player in the global biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#296 in Seoul

#825 in South Korea

#42,249 in the World

Seoul, South Korea

Ctc Bio, Inc.

Forward Citations = 14

33 inventors:

Bong-Sang Lee (10 out of 18 patents)

Hong Ryeol Jeon (7 out of 10 patents)

Do-Woo Kwon (7 out of 7 patents)

4. Su-Jun Park (7 out of 8 patents)

5. Hong-Ryeol Jeon (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ctc Bio, Inc.. Retrieved from https://idiyas.com/company/ctc-bio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…